Exploratory Study of Usefulness of 18F-BPA PET/CT in Clinical Staging of Malignancies
Phase 1
- Conditions
- patients with malignancies
- Registration Number
- JPRN-UMIN000008359
- Lead Sponsor
- "Hotta Group" of National Cancer Center Cancer Research and Development Fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
entered or entering to other clinical trials within 3 months Patients with uncontrollable diabetes or hypertension, with phenylketonuria, unstable angina, chronic renal disease or renal failure Patients who cannot undergo F18-FDG PET/CT Pregnant women or women who have the possibility to be pregnant Lactating women Patient who wants the partner be pregnant Patients with mental disorders whose entry to the clinical trial seems diffucult Patients who are considered to be ineligible by referring physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety of F18-BPA Biodistribution of F18-BPA Optimal imaging conditions of F18-BPA PET/CT
- Secondary Outcome Measures
Name Time Method Comparison of F18-BPA and F18-FDG PET/CT Comparison and evaluation of F18-BPA accumulations in the target lesions and their clinical characteristics